Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138965633> ?p ?o ?g. }
- W3138965633 abstract "Vinpocetine is widely used to treat cerebrovascular diseases. However, the effect of vinpocetine to treat hepatocellular carcinoma (HCC) has not been investigated. In this study, we revealed that vinpocetine was associated with antiproliferative activity in HCC cells, but induced cytoprotective autophagy, which restricted its antitumor activity. Autophagy inhibitors improved the antiproliferative activity of vinpocetine in HCC cells. Sorafenib is effective to treat advanced HCC, but the effect of autophagy induced by sorafenib is indistinct. We demonstrated vinpocetine plus sorafenib suppressed the cytoprotective autophagy activated by vinpocetine in HCC cells and significantly induced apoptosis and suppressed cell proliferation in HCC cells. In addition, vinpocetine plus sorafenib activates glycogen synthase kinase 3β (GSK-3β) and subsequently inhibits cytoprotective autophagy induced by vinpocetine in HCC cells. Meanwhile, overexpression of GSK-3β was efficient to increase the apoptosis induced by vinpocetine plus sorafenib in HCC cells. Our study revealed that vinpocetine plus sorafenib could suppress the cytoprotective autophagy induced by vinpocetine and subsequently show synergistically anti-HCC activity via activating GSK-3β and the combination of vinpocetine and sorafenib might reverse sorafenib resistance via the PI3K/protein kinase B/GSK-3β signaling axis. Thus, vinpocetine may be a potential candidate for sorafenib sensitization and HCC treatment, and our results may help to elucidate more effective therapeutic options for HCC patients with sorafenib resistance." @default.
- W3138965633 created "2021-03-29" @default.
- W3138965633 creator A5002047948 @default.
- W3138965633 creator A5008657300 @default.
- W3138965633 creator A5021326027 @default.
- W3138965633 creator A5021343595 @default.
- W3138965633 creator A5023541354 @default.
- W3138965633 creator A5037752030 @default.
- W3138965633 creator A5047835985 @default.
- W3138965633 creator A5057209908 @default.
- W3138965633 creator A5067509102 @default.
- W3138965633 creator A5074975483 @default.
- W3138965633 creator A5080721391 @default.
- W3138965633 date "2021-03-16" @default.
- W3138965633 modified "2023-10-02" @default.
- W3138965633 title "Enhanced anticancer activity by the combination of vinpocetine and sorafenib via PI3K/AKT/GSK-3β signaling axis in hepatocellular carcinoma cells" @default.
- W3138965633 cites W1500897968 @default.
- W3138965633 cites W1842457464 @default.
- W3138965633 cites W185221403 @default.
- W3138965633 cites W1990095055 @default.
- W3138965633 cites W2002394305 @default.
- W3138965633 cites W2004708536 @default.
- W3138965633 cites W2013568031 @default.
- W3138965633 cites W2023752098 @default.
- W3138965633 cites W2046258602 @default.
- W3138965633 cites W2058253589 @default.
- W3138965633 cites W2136149033 @default.
- W3138965633 cites W2140765540 @default.
- W3138965633 cites W2159590941 @default.
- W3138965633 cites W2318673311 @default.
- W3138965633 cites W2593253321 @default.
- W3138965633 cites W2598230851 @default.
- W3138965633 cites W2758002845 @default.
- W3138965633 cites W2762970417 @default.
- W3138965633 cites W2768141369 @default.
- W3138965633 cites W2770940099 @default.
- W3138965633 cites W2898767814 @default.
- W3138965633 cites W2921932752 @default.
- W3138965633 cites W2925825010 @default.
- W3138965633 cites W2932470287 @default.
- W3138965633 cites W2980431614 @default.
- W3138965633 cites W2998286622 @default.
- W3138965633 cites W65155625 @default.
- W3138965633 doi "https://doi.org/10.1097/cad.0000000000001056" @default.
- W3138965633 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33735117" @default.
- W3138965633 hasPublicationYear "2021" @default.
- W3138965633 type Work @default.
- W3138965633 sameAs 3138965633 @default.
- W3138965633 citedByCount "3" @default.
- W3138965633 countsByYear W31389656332021 @default.
- W3138965633 countsByYear W31389656332022 @default.
- W3138965633 countsByYear W31389656332023 @default.
- W3138965633 crossrefType "journal-article" @default.
- W3138965633 hasAuthorship W3138965633A5002047948 @default.
- W3138965633 hasAuthorship W3138965633A5008657300 @default.
- W3138965633 hasAuthorship W3138965633A5021326027 @default.
- W3138965633 hasAuthorship W3138965633A5021343595 @default.
- W3138965633 hasAuthorship W3138965633A5023541354 @default.
- W3138965633 hasAuthorship W3138965633A5037752030 @default.
- W3138965633 hasAuthorship W3138965633A5047835985 @default.
- W3138965633 hasAuthorship W3138965633A5057209908 @default.
- W3138965633 hasAuthorship W3138965633A5067509102 @default.
- W3138965633 hasAuthorship W3138965633A5074975483 @default.
- W3138965633 hasAuthorship W3138965633A5080721391 @default.
- W3138965633 hasConcept C185592680 @default.
- W3138965633 hasConcept C190283241 @default.
- W3138965633 hasConcept C203522944 @default.
- W3138965633 hasConcept C2778019345 @default.
- W3138965633 hasConcept C2778695046 @default.
- W3138965633 hasConcept C2778788455 @default.
- W3138965633 hasConcept C502942594 @default.
- W3138965633 hasConcept C55493867 @default.
- W3138965633 hasConcept C71924100 @default.
- W3138965633 hasConcept C75217442 @default.
- W3138965633 hasConcept C86554907 @default.
- W3138965633 hasConcept C98274493 @default.
- W3138965633 hasConceptScore W3138965633C185592680 @default.
- W3138965633 hasConceptScore W3138965633C190283241 @default.
- W3138965633 hasConceptScore W3138965633C203522944 @default.
- W3138965633 hasConceptScore W3138965633C2778019345 @default.
- W3138965633 hasConceptScore W3138965633C2778695046 @default.
- W3138965633 hasConceptScore W3138965633C2778788455 @default.
- W3138965633 hasConceptScore W3138965633C502942594 @default.
- W3138965633 hasConceptScore W3138965633C55493867 @default.
- W3138965633 hasConceptScore W3138965633C71924100 @default.
- W3138965633 hasConceptScore W3138965633C75217442 @default.
- W3138965633 hasConceptScore W3138965633C86554907 @default.
- W3138965633 hasConceptScore W3138965633C98274493 @default.
- W3138965633 hasLocation W31389656331 @default.
- W3138965633 hasLocation W31389656332 @default.
- W3138965633 hasOpenAccess W3138965633 @default.
- W3138965633 hasPrimaryLocation W31389656331 @default.
- W3138965633 hasRelatedWork W1585268103 @default.
- W3138965633 hasRelatedWork W2031322368 @default.
- W3138965633 hasRelatedWork W2037440964 @default.
- W3138965633 hasRelatedWork W2085937712 @default.
- W3138965633 hasRelatedWork W2127153258 @default.
- W3138965633 hasRelatedWork W2147371753 @default.
- W3138965633 hasRelatedWork W2789463326 @default.
- W3138965633 hasRelatedWork W3002644491 @default.